Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma	DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, viral infectious disease	Active, not recruiting	Phase 2	2026-10-07		NCT04291885

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Melanoma and Skin Cancer Trials Limited	10

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alfred Hospital	Melbourne	Australia	2
Auckland City Hospital	Auckland	New Zealand	23
Cairns Hospital	Cairns	Australia	18
Calvary Mater Hospital	Sydney	Australia	1
Cancer Care Service, Bundaberg Base Hospital	Bundaberg	Australia	1
Cancer Care Service, Hervey Bay Hospital	Hervey Bay	Australia	1
Cancer Care Wollongong	Wollongong	Australia	7
Chris O'Brien Lifehouse	Sydney	Australia	8
Icon Cancer Centre Hobart	Hobart	Australia	11
Mackay Hospital and Health Service	Mackay	Australia	2
Melanoma Institute Australia	Sydney	Australia	3
Peter MacCallum Cancer Centre	Melbourne	Australia	149
Port Macquarie Base Hospital	Port Macquarie	Australia	10
Princess Alexandra Hospital	Woolloongabba	Australia	106
Royal Adelaide Hospital	Adelaide	Australia	132
Royal Brisbane and Woman's Hospital	Brisbane	Australia	2
Royal North Shore Hospital	Sydney	Australia	14
Tasman Health Care	Southport	Australia	6
Townsville Hospital	Townsville	Australia	2
Westmead Hospital	Sydney	Australia	32

Clinical trials